Skip to main content

Abbott Laboratories ratios

  • ABT · NYSE
  • Pharmaceuticals
  • Health Care Equipment
  • S&P 500
$108.52+1.18%Close 13 Nov 2026 · Market value $187.6B

In fiscal 2025 (the year to 31 Dec 2025), Abbott Laboratories had an operating margin of 18.2%, a return on equity of 13.1%, a return on invested capital of 9.9%.

From Abbott Laboratories's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025.

Annual

Abbott Laboratories ratios, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Gross margin55.9%57.3%57.1%58.3%53.2%53.3%53.2%54.5%57.1%56.4%54.7%58.4%58.5%56.6%57.0%56.1%55.2%55.4%56.4%
Operating margin17.7%19.3%20.3%17.3%7.6%7.1%10.9%12.8%14.1%14.5%5.7%11.9%14.2%15.5%19.6%19.2%16.2%16.3%18.2%
Net margin13.9%16.5%18.7%13.2%22.0%31.3%13.1%11.3%21.7%6.7%1.7%7.7%11.6%13.0%16.4%15.9%14.3%31.9%14.7%
Free cash flow margin13.6%19.3%20.1%22.0%34.9%39.5%11.1%12.8%9.1%10.0%16.2%16.0%14.1%16.5%20.1%17.9%12.6%15.1%16.7%
Return on equity20.3%27.7%28.3%20.2%20.0%23.3%9.9%9.8%20.7%6.7%1.9%7.7%12.0%14.1%20.6%19.1%15.2%31.1%13.1%
Return on assets9.3%11.3%10.5%8.7%2.5%1.7%3.8%4.2%5.7%4.8%1.9%4.1%6.1%6.9%9.8%9.3%7.5%7.0%7.4%
Return on capital employed15.0%18.5%17.7%14.7%3.7%2.8%4.9%8.1%9.1%7.8%2.8%5.8%7.9%9.1%13.7%13.8%10.9%10.8%11.7%
Return on invested capital12.1%15.7%15.7%12.4%3.5%2.6%6.0%5.9%7.5%7.7%2.8%5.3%7.5%8.9%13.6%13.4%10.6%9.4%9.9%
Current ratio1.541.471.791.291.542.362.021.301.544.022.261.621.441.721.851.631.641.671.58
Debt to equity0.690.650.710.830.630.770.260.360.421.070.900.640.610.610.540.490.410.320.27
Net debt / EBITDA1.460.850.781.551.571.28−0.400.810.660.743.992.231.981.470.750.670.880.730.47
Interest coverage7.7210.7712.0011.014.544.2514.7117.3317.597.021.734.426.769.8115.8114.9910.1712.2116.33
Cash conversion97.8%117%108%167%159%126%84.6%114%42.0%149%930%207%122%127%122%113%88.4%47.4%113%
Dividend payout54.3%44.5%42.0%57.7%62.3%53.4%34.2%58.8%32.6%110%388%83.4%61.6%57.0%45.3%47.7%62.1%28.6%63.1%
SBC / Revenue1.7%1.2%1.2%1.1%1.8%2.3%1.3%1.2%1.4%1.5%1.5%1.6%1.6%1.6%1.5%1.6%1.6%1.6%1.5%

Quarterly

Abbott Laboratories ratios, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Gross margin55.5%55.2%55.6%55.8%55.0%56.9%56.4%55.4%57.0%56.2%57.7%56.8%
Operating margin17.4%13.9%16.1%17.5%17.4%16.3%18.4%18.1%19.6%12.0%13.4%10.4%
Net margin15.6%12.3%12.5%15.5%84.1%12.8%16.0%14.5%15.5%9.6%7.4%7.1%
Free cash flow margin22.3%6.3%13.8%20.2%19.6%9.0%13.9%20.2%22.9%8.2%15.8%9.4%
Return on equity4.1%3.2%3.3%4.1%19.4%2.7%3.5%3.2%3.4%2.1%1.8%1.8%
Return on assets2.2%1.6%1.9%2.1%1.9%1.5%2.0%1.8%2.0%0.9%0.9%0.9%
Return on capital employed3.0%2.4%2.8%3.1%2.8%2.5%2.9%3.0%3.2%1.5%1.9%1.5%
Return on invested capital3.0%2.2%2.5%2.9%2.5%2.0%2.7%2.5%2.6%1.1%1.2%1.1%
Current ratio1.641.601.681.601.671.781.821.701.581.391.381.45
Debt to equity0.410.380.380.380.320.270.270.250.270.650.640.61
Net debt / EBITDA3.313.623.052.702.692.612.181.831.7112.459.8110.28
Interest coverage11.199.8311.9213.0914.0512.9216.9617.0018.767.734.823.88
Cash conversion143%51.2%110%131%23.3%70.4%86.8%139%148%85.1%215%133%
Dividend payout55.7%78.1%73.8%58.3%10.4%77.4%57.8%62.7%58.0%102%119%119%
SBC / Revenue1.1%3.1%1.4%1.1%1.0%2.8%1.3%1.1%1.0%2.8%1.3%1.1%

The main figures as JSON and plain text. See data and methodology.

ABT in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.